InvestorsHub Logo
Followers 69
Posts 7606
Boards Moderated 0
Alias Born 01/10/2014

Re: Tasso1 post# 315716

Saturday, 06/19/2021 8:11:10 AM

Saturday, June 19, 2021 8:11:10 AM

Post# of 462055
Interesting, these trials are to study and further develop ERP/EEG biomarker measures.

Primary objectives are to quantify the effect size of ketamine-induced changes on MMN from a duration-deviant auditory oddball ERP test and to quantify the variability of ketamine-induced changes on MMN from a duration-deviant auditory oddball ERP test.



Interesting pure scientific research in partnership with an interesting cast of companies participating.

Alkermes, Inc.
Anavex Life Sciences Corp.
Astellas Pharma Inc
H. Lundbeck A/S
Merck Sharp & Dohme Corp.
Novartis
Sage Therapeutics
Takeda
Apex Innovative Sciences
COGNISION


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News